Abeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond Zevaskyn (ABEO)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Upside (ABEO)

This article was written by Follow We target small and microcap biopharmaceuticals companies where our advantage…